Evaluation of the diurnal variation in the pharmacokinetics of zileuton in healthy volunteers

被引：8

作者：

Awni, WM ^{[1
]}

Locke, C ^{[1
]}

Dube, LM ^{[1
]}

Cavanaugh, JH ^{[1
]}

机构：

[1] ABBOTT LABS,CHICAGO,IL

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1997年 / 37卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1997.tb04316.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The diurnal variation in the pharmacokinetic parameters of zileuton were evaluated in 12 healthy male volunteers in a three-period study. Periods I and II constituted a balanced, randomized, crossover study in which a participant received a single dose of 600-mg zileuton either at 7 AM or 11 PM. In period III all participants received 600-mg doses four times daily for 5 days. The differences between the pharmacokinetics of single doses of zileuton administered at 7 AM and at 11 PM were not statistically significant. Plasma concentration-time profiles of zileuton during the four daily dose intervals at steady state were also similar. Values for the pharmacokinetic parameters of zileuton after multiple doses were similar to those after single doses, with a minimal accumulation of the drug after multiple doses. Overall, there was little or no diurnal variation in the pharmacokinetic parameters of zileuton after single and multiple doses.

引用

页码：388 / 394

页数：7

共 8 条

[1]

Awni W M, 1995, Clin Pharmacokinet, V29 Suppl 2, P62

[2]

Awni W M, 1995, Clin Pharmacokinet, V29 Suppl 2, P22

[3]

Batt D G, 1992, Prog Med Chem, V29, P1, DOI 10.1016/S0079-6468(08)70004-3

[4] THE DISCOVERY AND DEVELOPMENT OF ZILEUTON - AN ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR [J].

BELL, RL ;

YOUNG, PR ;

ALBERT, D ;

LANNI, C ;

SUMMERS, JB ;

BROOKS, DW ;

RUBIN, P ;

CARTER, GW .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (03) :505-510

[5]

Granneman G R, 1995, Clin Pharmacokinet, V29 Suppl 2, P1

[6] THE EFFECT OF INHIBITION OF 5-LIPOXYGENASE BY ZILEUTON IN MILD-TO-MODERATE ASTHMA [J].

ISRAEL, E ;

RUBIN, P ;

KEMP, JP ;

GROSSMAN, J ;

PIERSON, W ;

SIEGEL, SC ;

TINKELMAN, D ;

MURRAY, JJ ;

BUSSE, W ;

SEGAL, AT ;

FISH, J ;

KAISER, HB ;

LEDFORD, D ;

WENZEL, S ;

ROSENTHAL, R ;

COHN, J ;

LANNI, C ;

PEARLMAN, H ;

KARAHALIOS, P ;

DRAZEN, JM .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1059-1066

[7] ON THE NATURE OF THE 5-LIPOXYGENASE REACTION IN HUMAN-LEUKOCYTES - ENZYME-PURIFICATION AND REQUIREMENT FOR MULTIPLE STIMULATORY FACTORS [J].

ROUZER, CA ;

SAMUELSSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (18) :6040-6044

[8]

Wong S L, 1995, Clin Pharmacokinet, V29 Suppl 2, P9

← 1 →